Berlin RemacableAn AI-Native Platform for Automatic Product Assignment in Medtech, to develop its AI technology, to expand its engineering team and to achieve a seed funds in Europe and the United States to achieve growth in the United States.
This round is led by Venture in the project, including the participation of Amino Collective and Helovers, and completed by business ashtors like Sass’s founder Boris Lokshin (Spricre systems) and industrial Timo Flareer.
“Controller requirements should not be slow to innovate – they should help accelerate it. Including the remacity, we turn the consent in a competitive advantage from a barrier,” David Buteller’sCo-founder and CEO of Remix. “Our goal is to bring up the life-saving medtech solutions-to bring faster to CT scanners from the care of the ware. We are grateful to our investors for supporting us in this outlook and rebuilding the artThe “
Remix was founded by David Boutalier and Florian skeleter in 2023. They believe that the regulatory requirements are necessary – but they should never retain innovation. With the rematacture, they help medoch companies to reduce the regulatory complications without quality or safety.
The platform uses AI to facilitate compliance workflies while developing a medical device. It translates regulations into structural, functional requirements – like MDR and FDA and integrate in the existing systems of their companies. It freely saves up to 90% of the regulatory documentation and coordination, freeing engineers to concentrate on-life-changing innovations.
According to Rematic, the regulatory requirements are one of the biggest challenges in the medtech industry: more than 40% of the R&D team is spent on manual regulatory functions – the time that can be used for innovation.
The AI-powered platform of RematiQ analyzes the Global Regulatory documents and provides functional requirements. They have been integrated in direct development and quality processes, reduced the documentation attempt by up to 90% and reduced the risk of adherence significantly.
“The volume and complications of international regulations continue to increase. We feel it every day-selling, clinical evaluation, regulatory approval and surveillance after market. An AI-based approach to manage the regulatory requirements — such as an an a Remataic-like-the right leverage adds to the exact point of the leverage” Mandy BloucherPLM Digitalization and Regulatory Intelligence are the heads of BRown Group.
RemachQuits have planned to develop the new capital its AI technology, expand its engineering team and use in Europe and the United States to run international growth.
Anton WetzAdded General Partner to Project A: “Remix is solving a mission-critical problem. Controller burden is slowing down many companies, but Rematiku offers a way to dramatically enhance skills – not compromising with quality or protection. The team has fascinated our deep industrial skills and a strong technology vision. We are eager to support them on this journey.“
[publish_date
